Inicio › Esteatosis hepática › Florida
Ensayos clínicos de Esteatosis hepática en Florida
21 estudios sobre Esteatosis hepática buscan participantes en Florida.
Ciudades en Florida
- Miami17 estudios
- Hialeah11 estudios
- Orlando10 estudios
- Cape Coral9 estudios
- Ocala8 estudios
- Doral7 estudios
- Sarasota6 estudios
- Homestead6 estudios
- Lakeland5 estudios
- Jacksonville5 estudios
- Spring Hill4 estudios
- West Palm Beach4 estudios
- Brandon4 estudios
- Kendall3 estudios
- Boca Raton3 estudios
- St. Petersburg3 estudios
- Melbourne3 estudios
- Gainesville3 estudios
- Town 'n' Country3 estudios
Texto oficial del estudio (inglés)
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Brandon
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami Lakes
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06613698A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Bradenton
- Akero Clinical Study Site, Brandon
- Akero Clinical Study Site, Coral Gables
- y 22 más
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 nov 2026 · NCT06528314Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Universal Axon Clinical Research, Doral
- Southwest General Healthcare Center, Fort Myers
- Genoma Research Group, Inc., Miami
- y 1 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 9 nov 2026 · NCT07631637A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Synergy Healthcare, Bradenton
- Synergy Healthcare, Bradenton
- Health Awareness, Inc., Jupiter
- y 6 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 9 nov 2026 · NCT07288138Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Med Research of Florida, LLC, Miami
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07854782A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Miami
- GSK Investigational Site, Viera
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 5 nov 2026 · NCT06920043A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Cape Coral
- GSK Investigational Site, Fort Myers
- GSK Investigational Site, Hialeah
- y 7 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Cape Coral
- GSK Investigational Site, Fort Myers
- GSK Investigational Site, Hialeah
- y 7 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07701993A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
- GSK Investigational Site, Miami Lakes
- GSK Investigational Site, Tampa
ReclutandoFase 1
Edades de 18 a 70 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07358546Evaluation of Non-Invasive Tests for Metabolic Liver Disease
- Clinical Pharmacology of Miami, Miami
ReclutandoEstudio observacional
Edades de 18 a 75 · Todos los sexos · Actualizado el 26 oct 2026 · NCT07122700A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Clermont
- 89bio Clinical Study Site, Fort Myers
- 89bio Clinical Study Site, Gainesville
- y 15 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 23 oct 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Brandon
- 89bio Clinical Study Site, Clermont
- 89bio Clinical Study Site, Fort Myers
- y 14 más
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT06318169A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- K2 Medical Research WINTER GARDEN, Clermont
- K2 Medical Research - Daytona Beach, Daytona Beach
- Care Access - Delray Beach, Delray Beach
- y 20 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07165028A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Health Awareness, Inc, Jupiter
- Evolution Clinical Trials, Miami
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07527910Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- University of Miami Health System, Miami
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 28 sept 2026 · NCT05832229A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Boynton Beach
- GSK Investigational Site, Cape Coral
- GSK Investigational Site, Clermont
- y 19 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 17 sept 2026 · NCT07221188Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
- AdventHealth Translational Research Institute, Orlando
ReclutandoSe aceptan voluntarios sanos
Edades de 25 a 55 · Todos los sexos · Actualizado el 12 ago 2026 · NCT06993454A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Boynton Beach
- GSK Investigational Site, Cape Coral
- GSK Investigational Site, Clermont
- y 20 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07221227A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Genoma Research Group, Inc, Miami
- Med Research of Florida, LLC, Miami
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 a 75 · Todos los sexos · Actualizado el 16 abr 2026 · NCT05648214Low-Dose Pioglitazone in Patients With NASH (AIM 2)
- University of Florida, Gainesville
ReclutandoFase 2
Edades de 21 a 75 · Todos los sexos · Actualizado el 4 abr 2025 · NCT04501406AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- AdventHealth Translational Research Institute, Orlando
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 mar 2025 · NCT04807868De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.